nVerses Capital’s GE HealthCare GEHC Stock Holding History

nVerses Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,929	Closed	-$351K	–	395
2026 Q1	$351K	Buy	+4,929	New	+$389K	0.32%	126

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

nVerses Capital's GEHC Position: Q2 2026 in Review

nVerses Capital sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 4,929 shares — an estimated $351K sold.

nVerses Capital first reported a position in GEHC in Q1 2026 and held it in 1 quarter. The position peaked at $351K in Q1 2026. 1,036 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

nVerses Capital reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 4,929 GE HealthCare shares in Q2 2026, an estimated $351K.
nVerses Capital first reported a position in GE HealthCare in Q1 2026 and held it in 1 quarter.
nVerses Capital's GE HealthCare position peaked at $351K in Q1 2026.
1,036 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.